Michael Ablinger

Salzburg, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Long-term cytokine exposure remodels the methylome and transcriptome of recessive dystrophic epidermolysis bullosa keratinocytes - a bioinformatic analysis.

Long-term cytokine exposure remodels the methylome and transcriptome of recessive dystrophic epidermolysis bullosa keratinocytes - a bioinformatic analysis.

Journal: Frontiers in cell and developmental biology

Published: February 13, 2026

Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.

Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.

Journal: The Journal of investigative dermatology

Published: June 25, 2025

Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.

Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.

Journal: The Journal of dermatology

Published: November 21, 2024

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Journal: International journal of molecular sciences

Published: December 01, 2023

MicroRNA-30d-5p-A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction.

MicroRNA-30d-5p-A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction.

Journal: Cells

Published: September 05, 2023

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.

Journal: Cancers

Published: April 13, 2023

MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.

MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.

Journal: The British journal of dermatology

Published: March 21, 2023

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents.

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents.

Journal: International journal of molecular sciences

Published: December 21, 2022

Topical Diacerein Decreases Skin and Splenic CD11c+ Dendritic Cells in Psoriasis.

Topical Diacerein Decreases Skin and Splenic CD11c+ Dendritic Cells in Psoriasis.

Journal: International journal of molecular sciences

Published: December 11, 2022

Transcriptome-Guided Drug Repurposing for Aggressive SCCs.

Transcriptome-Guided Drug Repurposing for Aggressive SCCs.

Journal: International journal of molecular sciences

Published: December 03, 2021

5'RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa.

5'RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa.

Journal: International journal of molecular sciences

Published: November 15, 2021

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.

Journal: International journal of molecular sciences

Published: February 26, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026